Faecal Calprotectin Shedding after Short-Term Treatment with Non-Steroidal Anti-Inflammatory Drugs

References

• Bjarnason I, Zanelli G, Smith T, Prouse P, Williams P, Smethurst P, et al. Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans. Gastroenterology 1987; 93: 480–9
   PubMed Web of Science ®Google Scholar
• Collins A J, Du Troit J A. Upper gastrointestinal findings and faecal occult blood in patients with rheumatic diseases taking nonsteroidal anti-inflammatory drugs. Br J Rheumatol 1987; 26: 295–8
   PubMedGoogle Scholar
• Bjarnason I, Zanelli G, Prouse P, Smethurst P, Smith T, Levi S, et al. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet 1987; 2: 711–4
   PubMed Web of Science ®Google Scholar
• Fliedner S H, Cronkite E P, Robertson J S. Granulopoiesis, senescence and random loss of neutrophilic granulocytes in human beings. Blood 1964; 24: 404–14
   Web of Science ®Google Scholar
• Segal A W, Ensell J, Munro J A, Sarner M. Indium 111 tagged leucocytes in the diagnosis of inflammatory bowel disease. Lancet 1981; 2: 230–2
   PubMed Web of Science ®Google Scholar
• Saverymuttu S H, Peters A M, Lavender J P, Hodgson H J, Chadwick V S. 111 Indium autologous leucocytes in inflammatory bowel disease. Gut 1983; 24: 293–9
   PubMed Web of Science ®Google Scholar
• Becker W, Fischbach W, Weppler M, Mosl B, Jacoby G, Börner W. Radiolabelled granulocytes in inflammatory bowel disease: diagnostic possibilities and clinical indications. Nucl Med Commun 1988; 9: 693–701
   PubMed Web of Science ®Google Scholar
• Nelson R L, Subramanian K, Gasparaitis A, Abcarian H, Pavel D G. 111Indium labelled granulocyte scan in the diagnosis and management of acute inflammatory bowel disease. Dis Colon Rectum 1990; 33: 451–7
   PubMed Web of Science ®Google Scholar
• Pullman W E, Sullivan P J, Barratt P J, Lising J, Booth J A, Doe W F. Assessment of inflammatory bowel disease activity by 99m Technetium phagocyte scanning. Gastroenterology 1988; 95: 989–96
   PubMed Web of Science ®Google Scholar
• Dale I, Brandtzaeg P, Fagerhol M K, Scott H. Distribution of a new myelocytic antigen (L1) in human peripheral blood leukocytes. Am J Clin Pathol 1985; 84: 24–34
   PubMed Web of Science ®Google Scholar
• Fagerhol M K, Andersson T, Næss-Andresen C F, Brandtzæg P, Dale I. Calprotectin (the L1 leukocyte protein). Stimulus response coupling: The role of intracellular calcium-binding proteins, V L Smith, J R Dedman. CRC Press Inc, Boca Raton, FL 1990; 187–210
   Google Scholar
• Røseth A G, Fagerhol M K, Aadland E, Schjønsby H. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 1992; 27: 793–8
   PubMed Web of Science ®Google Scholar
• Aabakken L, Larsen S, Osnes M. Visual Analogue Scales for endoscopic evaluation of nonsteroidal anti-inflammatory drug-induced mucosal damage in the stomach and duodenum. Scand J Gastroenterol 1990; 25: 443–8
   PubMed Web of Science ®Google Scholar
• Aabakken L, Osnes M. Gastroduodenal lesions induced by naproxen: an endoscopic evaluation of regional differences and natural course. Scand J Gastroenterol 1990; 25: 1215–22
   PubMed Web of Science ®Google Scholar
• Røseth A G, Kristinsson J, Fagerhol M K, Schjønsby H, Aadland E, Nygaard K, et al. Faecal calprotectin: a novel test for the diagnosis of colorectal cancer. Scand J Gastroenterol 1993; 28: 1073–6
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Zanelli G, Smith T, Smethurst P, Price A B, Gumpel M J, et al. The pathogenesis and consequence of non steroidal anti-inflammatory drug induced small intestinal inflammation in man. Scand J Rheumatol 1987, Suppl 64: 55–62
   Google Scholar
• Bjarnason I, Fehilly B, Smethurst P, Menzies I S, Levi A J. Importance of local versus systemic effects of non-steroidal anti-inflammatory drugs in increasing small intestinal permeability in man. Gut 1991; 32: 275–7
   PubMed Web of Science ®Google Scholar
• Bjarnason I. Experimental evidence of the benefit of misoprostol beyond the stomach in humans. J Rheumatol 1990; 20(Suppl)38–41
   Google Scholar
• Aabakken L, Osnes M. 51Cr-ethylenediaminetetraacetic acid absorption test: effects of naproxen, a non-steroidal, anti-inflammatory drug. Scand J Gastroenterol 1990; 25: 917–24
   PubMed Web of Science ®Google Scholar
• Lanza F L, Royer G L, Nelson R S. Endoscopic evaluation of the effects of aspirin, buffered aspirin and enteric-coated aspirin on gastric and duodenal mucosa. N Engl J Med 1980; 303: 136–8
   PubMed Web of Science ®Google Scholar
• Tronstad R I, Aadland E, Holler T, Olaussen B. Gastroscopic findings after treatment with enteric-coated and plain naproxen tablets in healthy subjects. Scand J Gastroenterol 1985; 20: 239–42
   PubMed Web of Science ®Google Scholar
• Aabakken L, Bjørnbeth B A, Hofstad B, Olaussen B, Larsen S, Osnes M. Comparison of the gastrointestinal side effects of naproxen formulated as plain tablets, enteric coated tablets or enteric coated granules in casules. Scand J Gastroenterol 1989; 24: 65–73
   PubMed Web of Science ®Google Scholar
• Bohbouth G E. General discussion. Activity related abnormalities in inflammatory bowel disease. University Hospital, Leiden 1988; 105–14
   Google Scholar
• Røseth A G, Aadland E, Schjønsby H, Fagerhol M K, Vatn M. Fecal calprotectin: a new marker of disease activity in IBD. Scand J Gastroenterol 1990; 25(Suppl 176)103
   PubMedGoogle Scholar
• Bjarnason I, O'Morain C, Levi A J, Peters T J. Absorption of 51chromium-labeled ethylene-diamine-tetraacetate in inflammatory bowel disease. Gastroenterology 1983; 85: 318–22
   PubMed Web of Science ®Google Scholar
• Bjarnason I, Williams P, So A, Zanelli G D, Levi A J, Gumpel J M, et al. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet 1984; 2: 1171–4
   PubMed Web of Science ®Google Scholar
• Graham D Y, Smith J L, Spjut H J, Torres E. Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology 1988; 95: 327–33
   PubMed Web of Science ®Google Scholar
• Hedenbro J L, Wetterberg P, Vallengren S, Bergquist L. Lack of correlation between fecal blood loss and drug-induced gastric mucosal lesions. Gastrointest Endosc 1988; 34: 247–51
   PubMed Web of Science ®Google Scholar
• Aabakken L, Dybdahl J H, Eidsaunet W, Haaland A, Larsen S, Osnes M. Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Scand J Gastroenterol 1989; 24: 1007–13
   PubMed Web of Science ®Google Scholar